Zobrazeno 1 - 10
of 409
pro vyhledávání: '"Ailsa, Hart"'
Autor:
Adrian C Bateman, Bu Hayee, Sunil Dolwani, Ailsa Hart, James E East, A John Morris, Ibrahim Al Bakir, Tim Raine, Nigel J Trudgill, Anjan Dhar, Marco Novelli, Matt Rutter, Gaurav Bhaskar Nigam, Misha Kabir, Ana Wilson, Shahida Din, Venkataraman Subramanian, Neil A Shepherd, Morris Gordon, Christopher Andrew Lamb, Simon Leedham, Chris Healey, O D Faiz, Lydia White, Ruth Wakeman, Maggie Vance, Vassiliki Sinopoulou
Publikováno v:
BMJ Open Gastroenterology, Vol 11, Iss 1 (2024)
Introduction The evolving landscape of inflammatory bowel disease (IBD) necessitates refining colonoscopic surveillance guidelines. This study outlines methodology adopted by the British Society of Gastroenterology (BSG) Guideline Development Group (
Externí odkaz:
https://doaj.org/article/5e863b48e5a64f3dafc519709aba76ee
Autor:
Stuart Bloom, Christian Selinger, Ailsa Hart, Christopher Lamb, Anjan Dhar, Helen Steed, Matthew Brookes, Jonathan Macdonald, Ian Arnott, Shellie Radford, Susan Ritchie, Victoria Fletcher, Jonathan Segal, N Sharma, Daniel Gaya, J Butterworth, S Andrews, P Adams, Deborah Morris, Pearl Avery, Philip Oppong, Mario Guslandi, Maro Kyriacou, Rachel Linger, Madhoor Ramdeen, John Appleton, John Anneh, B Kussel
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Background Refractory ulcerative proctitis presents a huge clinical challenge not only for the patients living with this chronic, progressive condition but also for the professionals who care for them. Currently, there is limited research and evidenc
Externí odkaz:
https://doaj.org/article/c891318c360b4ee4990b9c3c260e62f8
Autor:
Alessandro Armuzzi, Ailsa Hart, Joseph C. Cappelleri, Nadir Mammar, Peter Hur, Benjamin Hoskin, Fritha Hennessy, Gary Milligan, Axel Dignass
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background To describe variations in treatment patterns, clinical outcomes, patient-reported outcomes (PRO), and physician and patient satisfaction in patients with moderate-to-severe ulcerative colitis (UC) treated with tofacitinib in a rea
Externí odkaz:
https://doaj.org/article/3484e9af9b88449bb7f7467af1130a07
Autor:
James L. Alexander, Benjamin H. Mullish, Nathan P. Danckert, Zhigang Liu, Marton L. Olbei, Aamir Saifuddin, Melissa Torkizadeh, Hajir Ibraheim, Jesús Miguéns Blanco, Lauren A. Roberts, Claire M. Bewshea, Rachel Nice, Simeng Lin, Hemanth Prabhudev, Caroline Sands, Verena Horneffer-van der Sluis, Matthew Lewis, Shaji Sebastian, Charlie W. Lees, Julian P. Teare, Ailsa Hart, James R. Goodhand, Nicholas A. Kennedy, Tamas Korcsmaros, Julian R. Marchesi, Tariq Ahmad, Nick Powell
Publikováno v:
EBioMedicine, Vol 88, Iss , Pp 104430- (2023)
Summary: Background: Patients with inflammatory bowel disease (IBD) treated with anti-TNF therapy exhibit attenuated humoral immune responses to vaccination against SARS-CoV-2. The gut microbiota and its functional metabolic output, which are perturb
Externí odkaz:
https://doaj.org/article/81748891479c4744b4c014c27869b064
Autor:
Christine Norton, Jonathan Syred, Sally Kerry, Micol Artom, Louise Sweeney, Ailsa Hart, Wladyslawa Czuber-Dochan, Stephanie J. C. Taylor, Borislava Mihaylova, Chris Roukas, Qasim Aziz, Laura Miller, Richard Pollok, Sonia Saxena, Imogen Stagg, Helen Terry, Zohra Zenasni, Lesley Dibley, Rona Moss-Morris
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-18 (2021)
Abstract Background Despite being in clinical remission, many people with inflammatory bowel disease (IBD) live with fatigue, chronic abdominal pain and bowel urgency or incontinence that limit their quality of life. We aim to test the effectiveness
Externí odkaz:
https://doaj.org/article/9a1b22eb331c40eebc16485552e1c93f
Autor:
Lesley Dibley, Ailsa Hart, Julie Duncan, Charles H. Knowles, Sally Kerry, Doris Lanz, Vladislav Berdunov, Vichithranie W. Madurasinghe, Tiffany Wade, Helen Terry, Azmina Verjee, Mandy Fader, Christine Norton
Publikováno v:
Journal of Wound, Ostomy & Continence Nursing. 50:235-244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0d631db27cad9921c05522fafe971d1
https://doi.org/10.1097/won.0000000000000979
https://doi.org/10.1097/won.0000000000000979
Autor:
Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N Bernstein, Gilaad G Kaplan, Dana Duricova, Dan Greenberg, Hans O Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valérie E H Pittet, Vito Annese, KT Park, Konstantinos H Katsanos, Marte L Høivik, Zeljko Krznaric, María Chaparro, Edward V Loftus, Peter L Lakatos, Javier P Gisbert, Willem Bemelman, Bjorn Moum, Richard B Gearry, Michael D Kappelman, Ailsa Hart, Marieke J Pierik, Jane M Andrews, Siew C Ng, Renata D'Inca, Pia Munkholm
Publikováno v:
The Lancet Gastroenterology & Hepatology. 8:458-492
The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease and ulcerative colitis in both developed and newly industrialised coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f439bbec157cb3b05f668e94ca706f
https://doi.org/10.1016/s2468-1253(23)00003-1
https://doi.org/10.1016/s2468-1253(23)00003-1
Autor:
Danny Liew, Ailsa Hart, Niels Vande Casteele, Jordi Rimola, Jane M Andrews, Jakob Begun, Susan Connor, Astrid-Jane Williams, Yang Wu, Wei Xuan, Nik Sheng Ding, Bonita Gu, Michael De Gregorio, Joseph Louis Pipicella, William Connell, Basil D’Souza, Ali Gholamrezaei, Graham Radford-Smith, Tom Sutherland, Catherine Toong, Rodney Woods, Watson Ng
Publikováno v:
BMJ Open, Vol 11, Iss 7 (2021)
Introduction Perianal fistulising Crohn’s disease (pfCD) can be somewhat treatment refractory. Higher infliximab trough levels (TLIs) may improve fistula healing rates; however, it remains unclear whether escalating infliximab therapy to meet highe
Externí odkaz:
https://doaj.org/article/3861d699409d4ceaa390c70316272326
Autor:
Ashish Awasthi, Jamie Barbour, Andrew Beggs, Pradeep Bhandari, Daniel Blakeway, Matthew Brookes, James Brown, Matthew Brown, Germaine Caldwell, Samuel Clokie, Ben Colleypriest, Abby Conlin, Shanika de Silva, John de Caestecker, Jonathan Deeks, Anjan Dhar, Mark Dilworth, Edward Fogden, Stephen Foley, Deb Ghosh, Leonie Grellier, Ailsa Hart, Syed Samiul Hoque, Marietta Iacucci, Tariq Iqbal, Jonathan James, Mark Jarvis, Anthoor Jayaprakash, Satish Keshav, Laura Magill, Glenn Matthews, Joel Mawdsley, Simon McLaughlin, Samir Mehta, Kevin Monahan, Dion Morton, Senthil Murugesan, Miles Parkes, Valerie Pestinger, Chris Probert, Arvind Ramadas, Alessandro Rettino, Shaji Sebastian, Naveen Sharma, Michael Griffiths, Joanne Stockton, Venkat Subramanian, Nigel Suggett, Philippe Taniere, Julian Teare, Ajay M Verma, Yvonne Wallis
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 8, Iss 1 (2021)
Background: Chronic ulcerative colitis is a large bowel inflammatory condition associated with increased colorectal cancer risk over time, resulting in 1000 colectomies per year in the UK. Despite intensive colonoscopic surveillance, 50% of cases pro
Externí odkaz:
https://doaj.org/article/0dc01abacbe24fca9990d9312a441d4a
Publikováno v:
United European Gastroenterology Journal. 10:1054-1062
Patients with longstanding extensive colitis are at an increased risk of developing colorectal cancer (CRC), and are therefore enrolled into colonoscopy screening programmes with the aim of detecting pre-cancerous dysplastic change. However, current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd17cca0af79df74f2e8722cad10eea5
https://doi.org/10.1002/ueg2.12330
https://doi.org/10.1002/ueg2.12330